# A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

> **NCT06952699** · PHASE2 · RECRUITING · sponsor: **Takeda** · enrollment: 88 (estimated)

## Conditions studied

- Narcolepsy Type 2

## Interventions

- **DRUG:** TAK-360
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06952699
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-08-20
- **Final completion:** 2026-08-20
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952699, "A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06952699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*